Austin Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$389K Buy
15,636
+185
+1% +$4.67K 0.03% 207
2025
Q3
$394K Sell
15,451
-416
-3% -$10.3K 0.03% 210
2025
Q2
$385K Sell
15,867
-3,565
-18% -$83.1K 0.03% 205
2025
Q1
$492K Buy
19,432
+288
+2% +$7.54K 0.04% 164
2024
Q4
$508K Buy
19,144
+4,285
+29% +$116K 0.05% 144
2024
Q3
$430K Sell
14,859
-586
-4% -$17.1K 0.04% 157
2024
Q2
$432K Sell
15,445
-4,944
-24% -$136K 0.05% 133
2024
Q1
$555K Buy
20,389
+2,989
+17% +$82.9K 0.06% 115
2023
Q4
$501K Buy
17,400
+3,017
+21% +$91.2K 0.06% 109
2023
Q3
$477K Buy
14,383
+2,135
+17% +$75.5K 0.07% 94
2023
Q2
$449K Buy
12,248
+723
+6% +$28.1K 0.06% 101
2023
Q1
$470K Buy
11,525
+2,382
+26% +$103K 0.08% 90
2022
Q4
$468K Sell
9,143
-1,696
-16% -$81.3K 0.08% 91
2022
Q3
$474K Sell
10,839
-1,867
-15% -$90.7K 0.1% 72
2022
Q2
$666K Sell
12,706
-1,225
-9% -$62.4K 0.15% 55
2022
Q1
$721K Sell
13,931
-249
-2% -$12.9K 0.14% 55
2021
Q4
$837K Sell
14,180
-34
-0.2% -$1.69K 0.17% 49
2021
Q3
$611K Buy
14,214
+284
+2% +$12.6K 0.13% 65
2021
Q2
$546K Sell
13,930
-680
-5% -$26.4K 0.13% 65
2021
Q1
$529K Sell
14,610
-1,492
-9% -$53K 0.14% 57
2020
Q4
$593K Buy
16,102
+6,527
+68% +$239K 0.17% 51
2020
Q3
$333K Sell
9,575
-1,080
-10% -$37.9K 0.12% 63
2020
Q2
$331K Buy
10,655
+854
+9% +$29K 0.14% 57
2020
Q1
$304K Sell
9,801
-228
-2% -$7.77K 0.18% 53
2019
Q4
$373K Buy
+10,029
New +$357K 0.19% 54

Other funds holding PFE

Austin Private Wealth's PFE Position: Q4 2025 in Review

Austin Private Wealth increased its Pfizer (PFE) stake by 1.2% in Q4 2025, buying an estimated $4.67K and bringing the position to 15,636 shares worth $389K. The position accounts for 0.03% of the portfolio, ranked #207.

Austin Private Wealth first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $837K in Q4 2021. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Austin Private Wealth held 15,636 shares of Pfizer worth $389K as of Q4 2025.
  • Austin Private Wealth bought 185 Pfizer shares in Q4 2025, an estimated $4.67K.
  • Pfizer made up 0.03% of Austin Private Wealth's portfolio in Q4 2025, its #207 holding.
  • Austin Private Wealth first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • Austin Private Wealth's Pfizer position peaked at $837K in Q4 2021.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Austin Private Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.